Director: Elizabeth A. Walker, PhD, RN, CDE
Click image to view larger
Download 2-page P&C Core description (PDF)
Through efficacy studies and epidemiology, the Einstein Prevention and Control Core (P&C) links basic science into the realm of applied effectiveness and translational research for broad implementation. The Core emphasizes dissemination and sustainability through its community engagement, focusing on the problems of underserved minority populations that are particularly relevant in the Bronx, the poorest urban county in the U.S. with high diabetes prevalence.
The P&C Core provides core support across a broad range of research and community projects for primary, secondary and tertiary prevention in diabetes and related conditions.
Through three sub-cores, this core provides the focal point for addressing health disparities among the minority populations and underserved communities.
- The Behavioral Intervention and Evaluation Methodology (BIEM) sub-core of the P&C Core facilitates the development and implementation of behavioral interventions and provides comprehensive evaluation support for research to prevent and control diabetes and its complications.
- The Einstein Social-Environmental Research Methodology (SERM) sub-core increases community and social capital development and engages the community in diabetes-related research to reduce health disparities.
- The Clinical Research Methodology (CRM) sub-core promotes high-quality diabetes translational research through consultation, training, and mentoring in clinical research methods applicable to diabetes.
The collective expertise of the P&C's faculty spans health promotion, self-management behaviors, lifestyle interventions for obesity, evaluation, clinical diabetes research, and biostatistics.
- Elizabeth A. Walker, PhD, RN, CDE, director of the P&C and leader of the SERM, provides scientific direction and expertise in educational and behavioral science, health services, clinical nursing research, and promotion of collaborations with health disparities initiatives.
- Jill P. Crandall, MD, Associate Professor of Medicine and Director of the Montefiore/Einstein Diabetes Clinical Trials Unit, is leader of the CRMU.
- Judith Wylie-Rosett, EdD, RD, Professor and Head of the Division of Behavioral and Nutritional Research in the Department of Epidemiology and Population Health, is leader of the BIEM.
Other Principal Faculty Members
- Charles Basch, PhD, Professor in the Department of Health and Behavior Studies at Columbia University Teachers College, provides expertise in all aspects of evaluation and intervention planning methods, including both qualitative and quantitative methods.
- Jeffrey Gonzalez, PhD, Assistant Professor of Clinical Health Psychology at Ferkauf Graduate School of Psychology and Medicine (Endocrinology) at Einstein, provides expertise in developing interventions to improve treatment adherence among patients with diabetes. His research has recently focused on the link between depression and distress and diabetes treatment nonadherence as a potential pathway for understanding the negative effects of depression on diabetes outcomes.
- Bruce Rapkin, PhD, chief for the Community Collaboration and Implementation Science Division in the Department of Epidemiology and Population Health, is an expert in community-based participatory research (CBPR), and his research focuses on how community-academic partnerships can reduce barriers and improve standard of care.
- Clyde Schechter MD, MA, Associate Professor of Family Medicine and of Epidemiology & Population Health, brings substantial experience in research utilizing large public-access databases (NHANES, etc.), cost analyses, and simulation modeling.
- Hal Strelnick, MD ,Professor of Clinical Family and Social Medicine and Dean of Community Engagement, provides expertise in community-based research.
- Sonia Suchday, PhD, a health psychologist and behavioral scientist, is program director of the Health Psychology Emphasis at the Ferkauf Graduate School of Psychology and co-director of the new Institute for Public Health Sciences located on the Einstein campus. Dr. Suchday provides crucial linkages among these entities and the DRC, while spearheading a major global health initiative in diabetes and cardiovascular disease in India.
- Joel Zonszein, MD, CDE, Director of the Clinical Diabetes Center at the University Hospital of the Albert Einstein College of Medicine and Professor of Clinical Medicine, has vast clinical experience in the area of diabetes, with a special interest in understanding cardiovascular disease in individuals with diabetes and/or the metabolic syndrome. He developed several programs for diabetes care delivery systems, with a focus on the underserved minority populations. He is a faculty member in the Einstein Hispanic Center of Excellence (HCOE) and a Scientific Director of the Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities (BxCREED).
- Rubina Heptulla, MD, Professor of Pediatrics (Endocrinology), is the Division Chief of Pediatric Endocrinology. Dr. Heptulla’s research focuses on discovering novel ways for delivery of multiple hormones along with preservation of beta cells; and examining the barriers to achieving delivery of patient treatments, specifically concerning the risk factors for adherence to regimens.